The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis

Journal of Leukocyte Biology

Volumn 94, Issue 4, 2013, Pages 803-811

  Guan, Qingdong ^a   Moreno, Sem ^a   Qing, Gefei ^a   Weiss, Carolyn R ^a   Lu, Lina ^b   Bernstein, Charles N ^a   Warrington, Richard J ^a   Ma, Yanbing ^c   Peng, Zhikang ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Cell based immunotherapy; Immune down regulation; Inflammatory bowel disease; Murine colitis

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL SUBPOPULATION; COCULTURE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOWN REGULATION; ENTERITIS; FEMALE; FLOW CYTOMETRY; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; SUPPRESSOR CELL;

CELL-BASED IMMUNOTHERAPY; IMMUNE DOWN-REGULATION; INFLAMMATORY BOWEL DISEASE; MURINE COLITIS;

ADOPTIVE TRANSFER; ANIMALS; BODY WEIGHT; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; COLITIS; CYTOKINES; DEXTRAN SULFATE; FEMALE; HEPATIC STELLATE CELLS; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MYELOID CELLS; SPLEEN; TRINITROBENZENESULFONIC ACID;

EID: 84884834982     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0113050     Document Type: Article

References (45)

1. Monteleone, G., Fina, D., Caruso, R., Pallone, F. (2006) New mediators of immunity and inflammation in inflammatory bowel disease. Curr. Opin. Gastroenterol. 22, 361-364.
2. Shih, D. Q., Targan, S. R. (2008) Immunopathogenesis of inflammatory bowel disease. World J. Gastroenterol. 14, 390-400.
3. Pizarro, T. T., Cominelli, F. (2007) Cytokine therapy for Crohn's disease: advances in translational research. Annu. Rev. Med. 58, 433-444.
4. Hardenberg, G., Steiner, T. S., Levings, M. K. (2011) Environmental influences on T regulatory cells in inflammatory bowel disease. Semin. Immunol. 23, 130-138.
5. Greten, T. F., Manns, M. P., Korangy, F. (2011) Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11, 802-807.
6. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22, 238-244.
7. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
8. Gabrilovich, D. I., Ostrand-Rosenberg, S., Bronte, V. (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268.
9. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802.
10. Young, M. R., Newby, M., Wepsic, H. T. (1987) Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47, 100-105.
11. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689.
12. Ochoa, A. C., Zea, A. H., Hernandez, C., Rodriguez, P. C. (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13, 721s-726s.
13. Kusmartsev, S., Gabrilovich, D. I. (2003) Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 74, 186-196.
14. Nagaraj, S., Gabrilovich, D. I. (2008) Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 68, 2561-2563.
15. Fujimura, T., Mahnke, K., Enk, A. H. (2010) Myeloid derived suppressor cells and their role in tolerance induction in cancer. J. Dermatol. Sci. 59, 1-6.
16. Nagaraj, S., Gabrilovich, D. I. (2010) Myeloid-derived suppressor cells in human cancer. Cancer J. 16, 348-353.
17. Ugel, S., Delpozzo, F., Desantis, G., Papalini, F., Simonato, F., Sonda, N., Zilio, S., Bronte, V. (2009) Therapeutic targeting of myeloid-derived suppressor cells. Curr. Opin. Pharmacol. 9, 470-481.
18. Arora, M., Poe, S. L., Oriss, T. B., Krishnamoorthy, N., Yarlagadda, M., Wenzel, S. E., Billiar, T. R., Ray, A., Ray, P. (2010) TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol. 3, 578-593.
19. Chou, H., Hsieh, C., Yang, H., Wang, L., Arakawa, Y., Brown, K., Wu, Q., Lin, F., Peters, M., Fung, J., Lu, L., Qian, S. (2011) Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells. Hepatology 53, 1007-1019.
20. Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Kruger, C., Bachmann, O., Westendorf, A. M., Buer, J., Liblau, R., Manns, M. P., Korangy, F., Greten, T. F. (2008) Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135, 871-881, 881. e1-881. e5.
21. Zhang, R., Ito, S., Nishio, N., Cheng, Z., Suzuki, H., Isobe, K. (2011) Up-regulation of Gr1+CD11b+ population in spleen of dextran sulfate sodium administered mice works to repair colitis. Inflamm. Allergy Drug Targets 10, 39-46.
22. Zhang, R., Ito, S., Nishio, N., Cheng, Z., Suzuki, H., Isobe, K. I. (2011) Dextran sulphate sodium increases splenic Gr1(+)CD11b(+) cells which accelerate recovery from colitis following intravenous transplantation. Clin. Exp. Immunol. 164, 417-427.
23. Guan, Q., Ma, Y., Hillman, C. L., Qing, G., Ma, A. G., Weiss, C. R., Zhou, G., Bai, A., Warrington, R. J., Bernstein, C. N., Peng, Z. (2011) Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis. Mol. Med. 17, 646-656.
24. Bai, A., Yong, M., Ma, A. G., Ma, Y., Weiss, C. R., Guan, Q., Bernstein, C. N., Peng, Z. (2010) Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis. J. Pharmacol. Exp. Ther. 333, 717-725.
25. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., Boirivant, M. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174, 3237-3246.
26. Hsieh, C. C., Chou, H. S., Yang, H. R., Lin, F., Bhatt, S., Qin, J., Wang, L., Fung, J. J., Qian, S., Lu, L. (2013) The Role of Complement Component 3 (C3) in Differentiation of Myeloid-Derived Suppressor Cells. Blood 121, 1760-1768.
27. Moriyama, I., Ishihara, S., Rumi, M. A., Aziz, M. D., Mishima, Y., Oshima, N., Kadota, C., Kadowaki, Y., Amano, Y., Kinoshita, Y. (2008) Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis. Lab. Invest. 88, 652-663.
28. Guan, Q., Ma, Y., Hillman, C. L., Ma, A., Zhou, G., Qing, G., Peng, Z. (2009) Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis. Vaccine 27, 7096-7104.
29. Guan, Q., Weiss, C. R., Qing, G., Ma, Y., Peng, Z. (2012) An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo. Immunotherapy 4, 1799-1807.
30. Ma, Y., Guan, Q., Bai, A., Weiss, C. R., Hillman, C., Ma, A. G., Zhou, G., Qing, G., Peng, Z. (2010) Targeting TGF-β1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis. Inflamm. Bowel Dis. 16, 1040-1050.
31. Haverkamp, J. M., Crist, S. A., Elzey, B. D., Cimen, C., Ratliff, T. L. (2011) In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur. J. Immunol. 41, 749-759.
32. Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., Montero, A. J. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58, 49-59.
33. Moline-Velazquez, V., Cuervo, H., Vila-Del Sol, V., Ortega, M. C., Clemente, D., de Castro, F. (2011) Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis. Brain Pathol. 21, 678-691.
34. Dilek, N., van Rompaey, N., Le Moine, A., Vanhove, B. (2010) Myeloidderived suppressor cells in transplantation. Curr. Opin. Organ Transplant. 15, 765-768.
35. Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K., Khoury, S. J. (2007) CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179, 5228-5237.
36. Singh, U. P., Singh, N. P., Singh, B., Hofseth, L. J., Taub, D. D., Price, R. L., Nagarkatti, M., Nagarkatti, P. S. (2012) Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice. Brain Behav. Immun. 26, 72-82.
37. Arora, M., Poe, S. L., Ray, A., Ray, P. (2011) LPS-induced CD11b(+)Gr1(int)F4/80(+) regulatory myeloid cells suppress allergeninduced airway inflammation. Int. Immunopharmacol. 11, 827-832.
38. Deshane, J., Zmijewski, J. W., Luther, R., Gaggar, A., Deshane, R., Lai, J. F., Xu, X., Spell, M., Estell, K., Weaver, C. T., Abraham, E., Schwiebert, L. M., Chaplin, D. D. (2011) Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol. 4, 503-518.
39. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., Bronte, V. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 32, 790-802.
40. Saleem, S. J., Martin, R. K., Morales, J. K., Sturgill, J. L., Gibb, D. R., Graham, L., Bear, H. D., Manjili, M. H., Ryan, J. J., Conrad, D. H. (2012) Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J. Immunol. 189, 511-515.
41. Lechner, M. G., Liebertz, D. J., Epstein, A. L. (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185, 2273-2284.
42. Zhou, Z., French, D. L., Ma, G., Eisenstein, S., Chen, Y., Divino, C. M., Keller, G., Chen, S. H., Pan, P. Y. (2010) Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 28, 620-632.
43. Zygmunt, B., Veldhoen, M. (2011) T helper cell differentiation more than just cytokines. Adv. Immunol. 109, 159-196.
44. Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis, E., Quiceno, D. G., Padhya, T., McCaffrey, T. V., Mc-Caffrey, J. C., Gabrilovich, D. I. (2010) HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207, 2439-2453.
45. Cui, X., Jin, Y., Hofseth, A. B., Pena, E., Habiger, J., Chumanevich, A., Poudyal, D., Nagarkatti, M., Nagarkatti, P. S., Singh, U. P., Hofseth, L. J. (2010) Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev. Res. (Phila.) 3, 549-559.